RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
RxSight (NASDAQ: RXST) will present at the Piper Sandler 37th Annual Healthcare Conference in New York City.
Management is scheduled to present on Wednesday, December 3, 2025 at 12:00 p.m. ET. A live and archived webcast will be available at the company's investor site.
RxSight (NASDAQ: RXST) parteciperà al Piper Sandler 37th Annual Healthcare Conference a New York City.
La direzione è prevista per mercoledì 3 dicembre 2025 alle 12:00 ET. Una diretta webcast in tempo reale e archiviata sarà disponibile sul sito degli investitori dell'azienda.
RxSight (NASDAQ: RXST) presentará en la Piper Sandler 37th Annual Healthcare Conference en la ciudad de Nueva York.
La dirección está programada para el miércoles, 3 de diciembre de 2025 a las 12:00 p.m. ET. Un webcast en vivo y archivado estará disponible en el sitio de inversionistas de la empresa.
RxSight (NASDAQ: RXST)은 뉴욕시에서 열리는 Piper Sandler 37th Annual Healthcare Conference에서 발표할 예정입니다.
경영진은 2025년 12월 3일 수요일 오후 12:00(동부표준시)에 발표하도록 예정되어 있습니다. 라이브 및 아카이브 웹캐스트가 회사의 투자자 사이트에서 제공됩니다.
RxSight (NASDAQ: RXST) sera présent au Piper Sandler 37th Annual Healthcare Conference à New York.
La direction est prévue pour le mercredi 3 décembre 2025 à 12h00 ET. Un webcast en direct et archivé sera disponible sur le site des investisseurs de l'entreprise.
RxSight (NASDAQ: RXST) wird auf der Piper Sandler 37th Annual Healthcare Conference in New York City präsentieren.
Die Geschäftsführung ist für Mittwoch, der 3. Dezember 2025 um 12:00 Uhr ET vorgesehen. Ein Live- und Archiv-Webcast wird auf der Investorenseite des Unternehmens verfügbar sein.
RxSight (NASDAQ: RXST) ستقدم في المؤتمر السنوي السابع والثلاثين للرعاية الصحية من Piper Sandler في مدينة نيويورك.
من المقرر أن تقدم الإدارة في الأربعاء 3 ديسمبر 2025 الساعة 12:00 ظهرًا بتوقيت الساحل الشرقي. سيكون هناك بث حي وبث مسجّل متاح على موقع المستثمرين الخاص بالشركة.
- None.
- None.
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City.
RxSight’s management is scheduled to present on Wednesday, December 3, 2025, at 12:00 p.m. Eastern Time. A live and archived webcast of the presentation will be available at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com